Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-034168

Director acquired 1,754 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ASELAGE STEVE Director 2019-12-01 Grant or award +1,754 $2.85 $4,999 23,426 D: show line 1 in the form
Loading xslF345X03/form4.xml…